1. (1) Within the class of bactericidal agents, only the following subclasses are approved for use by the clinician on a patient:

   1. (a) antibiotic ointments;
   2. (b) antimicrobial agents; and
   3. (c) bactericidal agents.

2. (2) Clinicians may use antibiotic ointments as directed by a licensed medical practitioner with prescriptive authority.

   1. (a) Antibiotic ointments act to kill bacteria and microbes.
   2. (b) Antibiotic ointments are indicated on culture-proven infected wounds.
   3. (c) Antibiotic ointments are contraindicated in patients with proven sensitivities or allergic reactions to the antibiotic prescribed.

3. (3) Clinicians may use antimicrobial agents as directed by a licensed medical practitioner with prescriptive authority.

   1. (a) Antimicrobial agents contain a broad spectrum-silver cascade that acts to reduce the bioburden in wounds for up to seven days.
   2. (b) Antimicrobial agents are indicated for managing full and partial thickness wounds and may be used over debrided or grafted partial thickness wounds.
   3. (c) Antimicrobial agents have no known contraindications.

4. (4) Clinicians may use bactericidal agents only for debridement as directed by a licensed medical practitioner with prescriptive authority.

   1. (a) Bactericidal agents act by killing bacteria.
   2. (b) Bactericidal agents are indicated for the presence of bacteria.
   3. (c) Bactericidal agents are contraindicated in patients with allergic or sensitive response to the agent.

Authorizing statute(s): 37-24-201, 37-24-202, MCA

Implementing statute(s): 37-24-108, 37-24-109, MCA

History: NEW, 2019 MAR p. 1743, Eff. 10/5/19.